Latest news

Insights

Top 10 Strategic Priorities for Pharma CEOs in 2027

Executive Summary The pharmaceutical industry is entering 2027 with a fundamentally different set of strategic challenges than it faced at...
Manufacturing

Aura Biosciences Refocuses on Ocular Oncology Programs and Cuts Workforce by 20%

Aura Biosciences is restructuring its operations under recently appointed Chief Executive Officer Natalie Holles, shifting its focus toward ocular...
Insights

Top 10 Trends Reshaping Pharmaceutical Sales

Executive Summary Pharmaceutical sales are undergoing one of the most significant transformations in decades. The traditional commercial model—built around face-to-face...
Clinical

MoonLake Reports Positive Phase 3 Results for Sonelokimab in Psoriatic Arthritis

MoonLake Immunotherapeutics has reported positive topline results from the phase 3 IZAR-1 trial evaluating its lead nanobody candidate, sonelokimab,...
Insights

Top 10 Technologies Accelerating Drug Discovery

Executive Summary Drug discovery is undergoing one of the most...
Regulatory

FDA Advisory Panel to Review Grail’s Galleri Multi-Cancer Blood Test in September

Grail said the U.S. Food and Drug Administration (FDA)...
Commercial

Actimed Reclaims Rights to Wasting Disease Drug; $126M Faraday Deal Dead

Actimed Therapeutics has regained worldwide rights to its muscle-wasting therapy S-oxprenolol, giving the company full control over the program...
Manufacturing

Ensoma Restructures Operations to Focus on EN-374 for X-Linked Chronic Granulomatous Disease

Boston-based biotechnology company Ensoma has carried out another organizational restructuring as it concentrates its resources on the development of...
Insights

What an Autonomous Clinical Trial Might Look Like by 2030

Executive Summary Clinical trials are undergoing one of the most significant transformations in pharmaceutical history. Advances in artificial intelligence (AI), digital...
Regulatory

Takeda’s Orzeyful Approved as First Orexin Agonist for Narcolepsy Type 1

The U.S. Food and Drug Administration (FDA) has approved...
Commercial

The biggest pharmaceutical deal ever would be the “unlikely” AstraZeneca-BMS mega-merger

Word spread that two big pharma players, Bristol Myers...
Commercial

Supernus and Indivior Agree to Create CNS-Focused Company in All-Stock Merger

Supernus Pharmaceuticals and Indivior Pharmaceuticals have agreed to combine in an all-stock merger that will create a central nervous...
Insights

From Data-Rich to Insight-Rich: Pharma’s Next Transformation

Executive Summary The pharmaceutical industry has become one of the most data-intensive industries in the world. Every stage of the pharmaceutical...
Commercial

Hinge Health to Buy Out Cylinder Health in a Deal Worth Over $100M

Hinge Health has agreed to acquire digital gastrointestinal care startup Cylinder Health as the company expands its platform beyond...
Commercial

Pfizer to cough up $345 million to resolve lawsuits over EpiPen price hikes.

Pfizer along with its two subsidiaries ̶ Maryland-based Meridian Medical Technologies and Tennessee-based King Pharmaceuticals
Commercial

CR Pharma and TSB enter partnership for Covid-19 antibody therapy in China

TSB Therapeutics has partnered with CR Pharma (China Resources...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

Regulatory

Manufacturing

Aura Biosciences Refocuses on Ocular Oncology Programs and Cuts Workforce by 20%

Aura Biosciences is restructuring its operations under recently appointed...
Insights

Top 10 Trends Reshaping Pharmaceutical Sales

Executive Summary Pharmaceutical sales are undergoing one of the most...
Clinical

MoonLake Reports Positive Phase 3 Results for Sonelokimab in Psoriatic Arthritis

MoonLake Immunotherapeutics has reported positive topline results from the...
Commercial

Jazz Pharmaceuticals to Acquire Actio for Up to $1.32 Billion to Add KCNT1 Epilepsy Therapy

Jazz Pharmaceuticals has agreed to acquire Actio Biosciences in...

Research & Development

Market Access

Manufacturing

Lilly Adds $4.5 Billion to Indiana Manufacturing Expansion, Total U.S. Commitments Exceed $50 Billion

Eli Lilly has announced an additional $4.5 billion investment...
Manufacturing

Lilly and Profluent Sign Up to $2.25 Billion Collaboration to Develop AI-Designed Genetic Medicines

Eli Lilly has entered into a multi-program research collaboration...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Top 10 Strategic Priorities for Pharma CEOs in 2027

Executive Summary The pharmaceutical industry is entering 2027 with a...
Editorial Team -
Manufacturing

Ensoma Restructures Operations to Focus on EN-374 for X-Linked Chronic Granulomatous Disease

Boston-based biotechnology company Ensoma has carried out another organizational...
Editorial Team -
Insights

Top 10 Trends Reshaping Pharmaceutical Sales

Executive Summary Pharmaceutical sales are undergoing one of the most...
Editorial Team -